Abstract:Two series of novel 2-arylvinyl-naphtho[2,3-d]imidazol-3-ium iodide derivatives and 2-arylvinyl-naphtho[2,3-d]imidazol-3-ium bromide derivatives were designed and synthesized by the structural combination of YM155 with stilbenoids. All compounds were tested for anti-proliferative activity against PC-3, A375 and HeLa human cancer cell lines. Two of the compounds were selected for further investigation: 12b, which showed potent cytotoxicity against the three tested cell lines with IC50 values in the range of 0.06-0.21 mu M, and 71, which displayed excellent selectivity for PC-3 cells with an IC50 of only 22 nM. Western blot analysis results indicated that both 12b and 71 suppress the expression of Bcl-2 and Survivin proteins, which helps induce apoptosis. As determined by the percent of Annexin V-FITC-positive apoptotic cells, 12b was not only significantly more effective than 71 at a concentration of 100 nM in PC-3 cells but also induced apoptosis in a dose-dependent manner with more potency than 71 at a concentration of 1000 nM in A375 cells. Therefore, compound 12b was chosen for further in-depth studies investigating the mechanism of apoptosis. The results showed that it could activate caspase-3, hydrolyze PARP, and even inactivate ERK. Moreover, 12b arrested A375 cells at S phase in a time dependent and dose-dependent manner, while having a visible effect on microtubule dynamics. In addition, (E)-2-(2-(1H-indol-3-yl)vinyl)-1-benzyl-3-(2-methoxyethyl)-4,9-dioxo-4,9-dihydro-1H-naphtho[2,3-d]imidazol-3-ium bromide (12b) exhibited significant antitumor activity when evaluated in a subcutaneous solid tumor model. Our study reveals that 2-arylvinyl-substituted naphtho[2,3-d]imidazolium scaffolding is a promising new entity for the development of multi-target anticancer drugs. (C) 2017 Published by Elsevier Masson SAS.

Synthesis and Antitumor Activity of Novel 4-Chloro-3-arylmaleimide Derivatives

Design, Synthesis, and Anticancer Activity Evaluation of Hybrids of Azoles and Barbituric Acids.

Synthesis and Cytotoxicity of Novel 3-Amido-4-indolylmaleimide Derivatives

Synthesis and Cytotoxicity of Indolopyrrolemaleimides

Synthesis and Antitumor Activity of Indolemalylimide Derivatives

Synthesis and biological evaluation of novel podophyllotoxin analogs as antitumor agents.

Synthesis and Cytotoxic Activity of Novel 1-((Indol-3-yl)methyl)–1h-imidazolium Salts

Synthesis and antitumor activity of novel 2-substituted indoline imidazolium salt derivatives

[Synthesis and Antitumor Activity of Arylsubstituted Imidazolin-2-one Derivatives].

Synthesis and Antitumor Activity of a Series of Novel N-aryl-5-(2,2,2-trifluoroethoxy)-1,5-dihydro-2H-pyrrol-2-ones Derivatives

Synthesis and Antitumor Activity of Novel Quinazoline Derivatives Containing Acrylamide

Synthesis and Biological Evaluation of Novel 2-Arylvinyl-substituted Naphtho[2,3-D]imidazolium Halide Derivatives As Potent Antitumor Agents

Synthesis and Antitumor Activity of 4-Tert-butyl-5-benzyl-2-benzyliminothiazoles

Synthesis And Anti-Tumor Study Of 3-Aryl-4-Oxo-Thiazolidin-2-Carboxylic Acid Amides

Synthesis and Antitumor Activity Evaluation of Novel 2-Amino-5-ethylpyrimidine Derivatives

Synthesis and antitumor activity of novel N-substituted tetrahydro-β-carboline-imidazolium salt derivatives.

Design and Synthesis of New Imatinib Analogs Containing Thiazolyl Moiety

Novel 4-Arylpolyhydroquinoline Derivatives: Synthesis and Inhibition of Human Cervical Cancer Cells

Synthesis and Anti-Tumor Activity Research of a Novel Series of 3-Amidebenzamide Derivatives

2,3-Disubstituted 8-Arylamino-3h-imidazo[4,5-g]quinazolines: A Novel Class of Antitumor Agents

Synthesis and Antitumor Activity of Novel 4-Aminoquinazoline Derivatives Containing Benzothiazole